These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 17826531

  • 1. BMS-275183-induced gene expression patterns in head and neck carcinoma.
    Yoo GH, Tran VR, Lemonnier LA, Ezzat WH, Subramanian G, Piechocki MP, Ensley JF, Lonardo F, Kim H, Lin HS.
    Am J Otolaryngol; 2007; 28(5):309-15. PubMed ID: 17826531
    [Abstract] [Full Text] [Related]

  • 2. XRP6258-induced gene expression patterns in head and neck cancer carcinoma.
    Yoo GH, Kafri Z, Ensley JF, Lonardo F, Kim H, Folbe AJ, Won J, Stevens T, Lin HS.
    Laryngoscope; 2010 Jun; 120(6):1114-9. PubMed ID: 20513026
    [Abstract] [Full Text] [Related]

  • 3. Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot.
    Yoo GH, Piechocki MP, Ensley JF, Nguyen T, Oliver J, Meng H, Kewson D, Shibuya TY, Lonardo F, Tainsky MA.
    Clin Cancer Res; 2002 Dec; 8(12):3910-21. PubMed ID: 12473607
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer.
    Yoo GH, Piechocki MP, Oliver J, Lonardo F, Zumstein L, Lin HS, Kim H, Shibuya TY, Shehadeh N, Ensley JF.
    Laryngoscope; 2004 Nov; 114(11):1871-9. PubMed ID: 15510008
    [Abstract] [Full Text] [Related]

  • 5. Docetaxel associated pathways in cisplatin resistant head and neck squamous cell carcinoma: a pilot study.
    Yoo GH, Lin HS, Iskander AJ, Piechocki MP, Oliver J, Kewson D, Lonardo F, Tainsky MA, Kim HR, Kim H, Ensley JF.
    Laryngoscope; 2005 Nov; 115(11):1938-46. PubMed ID: 16319602
    [Abstract] [Full Text] [Related]

  • 6. An in vivo evaluation of docetaxel delivered intratumorally in head and neck squamous cell carcinoma.
    Yoo GH, Subramanian G, Boinpally RR, Iskander A, Shehadeh N, Oliver J, Ezzat W, Piechocki MP, Ensley JF, Lin HS, Shibuya TY, Polin L, Parchment RE.
    Arch Otolaryngol Head Neck Surg; 2005 May; 131(5):418-29. PubMed ID: 15897421
    [Abstract] [Full Text] [Related]

  • 7. E1A-mediated suppression of EGFR expression and induction of apoptosis in head and neck squamous carcinoma cell lines.
    Flinterman M, Gäken J, Farzaneh F, Tavassoli M.
    Oncogene; 2003 Apr 03; 22(13):1965-77. PubMed ID: 12673202
    [Abstract] [Full Text] [Related]

  • 8. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy.
    Secades P, de Santa-María IS, Merlo A, Suarez C, Chiara MD.
    Head Neck; 2015 Aug 03; 37(8):1150-62. PubMed ID: 24798801
    [Abstract] [Full Text] [Related]

  • 9. The effects of exogenous p53 overexpression on HPV-immortalized and carcinogen transformed oral keratinocytes.
    Yoo GH, Washington J, Oliver J, Piechocki M, Kim H, Foster-Nora J, Shibuya TY, Wilson DR, Ensley JF.
    Cancer; 2002 Jan 01; 94(1):159-66. PubMed ID: 11815972
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin-mediated increases in survivin expression.
    Oh SH, Jin Q, Kim ES, Khuri FR, Lee HY.
    Clin Cancer Res; 2008 Mar 01; 14(5):1581-9. PubMed ID: 18316583
    [Abstract] [Full Text] [Related]

  • 11. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
    Patel V, Lahusen T, Leethanakul C, Igishi T, Kremer M, Quintanilla-Martinez L, Ensley JF, Sausville EA, Gutkind JS, Senderowicz AM.
    Clin Cancer Res; 2002 Nov 01; 8(11):3549-60. PubMed ID: 12429646
    [Abstract] [Full Text] [Related]

  • 12. Cyclin-dependent kinase inhibitor (roscovitine) suppresses growth and induces apoptosis by regulating Bcl-x in head and neck squamous cell carcinoma cells.
    Mihara M, Shintani S, Kiyota A, Matsumura T, Wong DT.
    Int J Oncol; 2002 Jul 01; 21(1):95-101. PubMed ID: 12063555
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling.
    Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB.
    Int J Cancer; 2004 Sep 20; 111(5):679-92. PubMed ID: 15252836
    [Abstract] [Full Text] [Related]

  • 14. The pregnane X receptor (PXR) and the nuclear receptor corepressor 2 (NCoR2) modulate cell growth in head and neck squamous cell carcinoma.
    Rigalli JP, Reichel M, Reuter T, Tocchetti GN, Dyckhoff G, Herold-Mende C, Theile D, Weiss J.
    PLoS One; 2018 Sep 20; 13(2):e0193242. PubMed ID: 29470550
    [Abstract] [Full Text] [Related]

  • 15. Antitumor effects of IDN5109 on head and neck squamous cell carcinoma.
    Sano D, Matsuda H, Ishiguro Y, Nishimura G, Kawakami M, Tsukuda M.
    Oncol Rep; 2006 Feb 20; 15(2):329-34. PubMed ID: 16391850
    [Abstract] [Full Text] [Related]

  • 16. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
    Lee DW, Park SW, Park SY, Heo DS, Kim KH, Sung MW.
    Head Neck; 2004 Aug 20; 26(8):706-15. PubMed ID: 15287038
    [Abstract] [Full Text] [Related]

  • 17. Anticancer activity and differentially expressed genes in head and neck cancer cells treated with a novel cyclin-dependent kinase inhibitor.
    Shin HC, Song DW, Baek WK, Lee SR, Kwon TK, Lee J, Park SH, Jang BC, Park JW.
    Chemotherapy; 2009 Aug 20; 55(5):353-62. PubMed ID: 19657189
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells.
    Matheny KE, Barbieri CE, Sniezek JC, Arteaga CL, Pietenpol JA.
    Laryngoscope; 2003 Jun 20; 113(6):936-9. PubMed ID: 12782800
    [Abstract] [Full Text] [Related]

  • 19. Tamoxifen inhibits the growth of head and neck cancer cells and sensitizes these cells to cisplatin induced-apoptosis: role of TGF-beta1.
    Tavassoli M, Soltaninia J, Rudnicka J, Mashanyare D, Johnson N, Gäken J.
    Carcinogenesis; 2002 Oct 20; 23(10):1569-75. PubMed ID: 12376463
    [Abstract] [Full Text] [Related]

  • 20. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
    Johnson FM, Saigal B, Talpaz M, Donato NJ.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6924-32. PubMed ID: 16203784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.